March 25, 2020 — According to a statement on March 24 from Commissioner of Food and Drugs - Food and Drug Administration Stephen M. Hahn, M.D., the U.S. Food and Drug Administration (FDA) took action to increase U.S. supplies to support the U.S. response to COVID-19 by providing instructions to manufacturers importing personal protective equipment and other devices.
Hahn stated: "One of FDA’s priorities in combating the COVID-19 pandemic is facilitating access to critical personal protective equipment (PPE) and devices. We are engaging with importers and others involved in the import trade community during this pandemic to facilitate the entry of needed products, including PPE, into the U.S. These instructions to importers clarify the types of PPE that can be imported without engaging with FDA. They also include information about the type of information importers can submit to facilitate their entries. We have adjusted our import screening to further expedite imports of legitimate products and are continually monitoring our import systems to prevent and mitigate any potential issues."
The FDA established a special email inbox, [email protected], for industry representatives to quickly communicate with the agency and address questions or concerns.
The agency is providing maximum flexibility to those seeking to bring PPE into the U.S. and are ready and available to engage with importers to minimize disruptions during the importing process.
Many companies are stepping up across America to help with manufacturing critical and life-saving medical supplies to strengthen the U.S. response. To support their efforts, we are setting up additional avenues of communication to FDA so they can contact us with any questions or concerns around the clock.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
For more information: www.fda.gov
Related Coronavirus Content:
CDRH Issues Letter to Industry on COVID-19
Qure.ai Launches Solutions to Help Tackle COVID19
ASRT Deploys COVID-19 Resources for Educational Programs
Study Looks at CT Findings of COVID-19 Through Recovery
VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)
The Cardiac Implications of Novel Coronavirus
CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)
Radiology Lessons for Coronavirus From the SARS and MERS Epidemics
Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic
Emerging Technologies Proving Value in Chinese Coronavirus Fight
Radiologists Describe Coronavirus CT Imaging Features
Coronavirus Update from the FDA
CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia
September 24, 2026 
